Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis

Abstract Introduction Previous works of literatures on the viral load suppression rate of third line antiretroviral therapy in Africa has produced inconsistent and inconclusive results, with rates varying between 62% and 95%. This variability poses challenges for policymakers and healthcare provider...

Full description

Saved in:
Bibliographic Details
Main Authors: Tilahun Degu Tsega, Sintayehu Simie Tsega, Asaye Alamneh Gebeyehu, Getaneh Atikilt Yemata, Rahel Mulatie Anteneh, Almaw Genet Yeshiwas, Getasew Yirdaw, Chalachew Yenew, Anley Shiferaw Enawgaw, Amare Genetu Ejigu, Ahmed Fentaw Ahmed, Zeamanuel Anteneh Yigzaw, Berhanu Abebaw Mekonnen, Meron Asmamaw Alemayehu, Abathun Temesgen, Abebaw Molla, Habitamu Mekonen, Assefa Andargie Kassa, Gashaw Melkie Bayeh
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-10576-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863222081421312
author Tilahun Degu Tsega
Sintayehu Simie Tsega
Asaye Alamneh Gebeyehu
Getaneh Atikilt Yemata
Rahel Mulatie Anteneh
Almaw Genet Yeshiwas
Getasew Yirdaw
Chalachew Yenew
Anley Shiferaw Enawgaw
Amare Genetu Ejigu
Ahmed Fentaw Ahmed
Zeamanuel Anteneh Yigzaw
Berhanu Abebaw Mekonnen
Meron Asmamaw Alemayehu
Abathun Temesgen
Abebaw Molla
Habitamu Mekonen
Assefa Andargie Kassa
Gashaw Melkie Bayeh
author_facet Tilahun Degu Tsega
Sintayehu Simie Tsega
Asaye Alamneh Gebeyehu
Getaneh Atikilt Yemata
Rahel Mulatie Anteneh
Almaw Genet Yeshiwas
Getasew Yirdaw
Chalachew Yenew
Anley Shiferaw Enawgaw
Amare Genetu Ejigu
Ahmed Fentaw Ahmed
Zeamanuel Anteneh Yigzaw
Berhanu Abebaw Mekonnen
Meron Asmamaw Alemayehu
Abathun Temesgen
Abebaw Molla
Habitamu Mekonen
Assefa Andargie Kassa
Gashaw Melkie Bayeh
author_sort Tilahun Degu Tsega
collection DOAJ
description Abstract Introduction Previous works of literatures on the viral load suppression rate of third line antiretroviral therapy in Africa has produced inconsistent and inconclusive results, with rates varying between 62% and 95%. This variability poses challenges for policymakers and healthcare providers in making informed decisions. This systematic review and meta-analysis aimed to determine the overall viral load suppression rate of third line antiretroviral therapy in Africa and to clarify the contradictory relationship between gender and viral load suppression, based on existing primary studies. Methods A systematic review and meta-analysis were conducted using PubMed, Medline, Cochrane Library, Henari, African Journals Online (AJOL), Web of science, and Google Scholar to access studies up to December 6, 2024. The PRISMA guideline, JBI, and Newcastle Ottawa quality assessment scale checklists were used. Heterogeneity was evaluated with Cochrane’s Q and I2 statistics. Publication bias was checked using a funnel plot, Begg’s and Egger’s test, followed by the DerSimonian and Laird random effects model. Meta-regression, subgroup and sensitivity analyses were also performed. The odds ratio with a 95% confidence interval was used to assess the association of gender with the viral load suppression rate in patients on third-line antiretroviral therapy. All analyses were conducted using Stata 18. Results A total of 14 primary studies with a total sample size of 1791 were included. The pooled magnitude of the viral load suppression rate was 79.82% (95%CI: 75.75%, 83.90%). Around 75% of the included studies’ heterogeneity were explained by country, study year, study settings and quality level of the study level variables. There was not statistically significant association of gender with viral load suppression rate of third line antiretroviral therapy. Conclusion and recommendation The pooled magnitude of the viral load suppression rate was 79.82%. There was not statistically significant association of gender with viral load suppression rate of third line antiretroviral therapy. Therefore, to maintain and further improve the strong viral load suppression rates of TLARVT in Africa, it is essential to focus on appropriate regimen selection, patient counseling and switching, adherence support, and regular viral load testing. Future studies with larger sample sizes should explore the association between gender and viral load suppression to provide conclusive findings.
format Article
id doaj-art-e21637eba3ae4d73bc7c00a8c15be049
institution Kabale University
issn 1471-2334
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-e21637eba3ae4d73bc7c00a8c15be0492025-02-09T12:14:50ZengBMCBMC Infectious Diseases1471-23342025-02-0125111710.1186/s12879-025-10576-4Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysisTilahun Degu Tsega0Sintayehu Simie Tsega1Asaye Alamneh Gebeyehu2Getaneh Atikilt Yemata3Rahel Mulatie Anteneh4Almaw Genet Yeshiwas5Getasew Yirdaw6Chalachew Yenew7Anley Shiferaw Enawgaw8Amare Genetu Ejigu9Ahmed Fentaw Ahmed10Zeamanuel Anteneh Yigzaw11Berhanu Abebaw Mekonnen12Meron Asmamaw Alemayehu13Abathun Temesgen14Abebaw Molla15Habitamu Mekonen16Assefa Andargie Kassa17Gashaw Melkie Bayeh18Department of Public Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Medical Nursing, School of Nursing, College of Medicine and Health Science, University of GondarDepatment of Public Health, College of Health Science, Debre Tabor UniversityDepatment of Public Health, College of Health Science, Debre Tabor UniversityDepatment of Public Health, College of Health Science, Debre Tabor UniversityDepartment of Environmental Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Environmental Health Science, College of Medicine and Health Sciences, Debre Markos UniversityDepartment of Environmental Health Sciences, Public Health, College of Health Sciences, Debre Tabor UniversityDepartment of Public Health, College of Health Sciences, Debre Markos UniversityDepartment of Midwifery, College of Medicine and Health Sciences, Injibara UniversityDepartment of Public Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Health Promotion and Behavioral Sciences, School of Public Health, College of Medicine and Health Sciences, Bahir Dar UniversityDepartment of Nutrition and Dietetics, School of Public Health, College of Medicine and Health Sciences, Bahir Dar UniversityDepartment of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of GondarDepartment of Environmental Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Public Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Human Nutrition, Collage of Health Science, Debre Markos UniversityDepartment of Public Health, College of Medicine and Health Sciences, Injibara UniversityDepartment of Environmental Health, College of Medicine and Health Sciences, Injibara UniversityAbstract Introduction Previous works of literatures on the viral load suppression rate of third line antiretroviral therapy in Africa has produced inconsistent and inconclusive results, with rates varying between 62% and 95%. This variability poses challenges for policymakers and healthcare providers in making informed decisions. This systematic review and meta-analysis aimed to determine the overall viral load suppression rate of third line antiretroviral therapy in Africa and to clarify the contradictory relationship between gender and viral load suppression, based on existing primary studies. Methods A systematic review and meta-analysis were conducted using PubMed, Medline, Cochrane Library, Henari, African Journals Online (AJOL), Web of science, and Google Scholar to access studies up to December 6, 2024. The PRISMA guideline, JBI, and Newcastle Ottawa quality assessment scale checklists were used. Heterogeneity was evaluated with Cochrane’s Q and I2 statistics. Publication bias was checked using a funnel plot, Begg’s and Egger’s test, followed by the DerSimonian and Laird random effects model. Meta-regression, subgroup and sensitivity analyses were also performed. The odds ratio with a 95% confidence interval was used to assess the association of gender with the viral load suppression rate in patients on third-line antiretroviral therapy. All analyses were conducted using Stata 18. Results A total of 14 primary studies with a total sample size of 1791 were included. The pooled magnitude of the viral load suppression rate was 79.82% (95%CI: 75.75%, 83.90%). Around 75% of the included studies’ heterogeneity were explained by country, study year, study settings and quality level of the study level variables. There was not statistically significant association of gender with viral load suppression rate of third line antiretroviral therapy. Conclusion and recommendation The pooled magnitude of the viral load suppression rate was 79.82%. There was not statistically significant association of gender with viral load suppression rate of third line antiretroviral therapy. Therefore, to maintain and further improve the strong viral load suppression rates of TLARVT in Africa, it is essential to focus on appropriate regimen selection, patient counseling and switching, adherence support, and regular viral load testing. Future studies with larger sample sizes should explore the association between gender and viral load suppression to provide conclusive findings.https://doi.org/10.1186/s12879-025-10576-4Third line antiretroviral therapyViral load suppressionAfricaHIVSystematic review and meta-analysis
spellingShingle Tilahun Degu Tsega
Sintayehu Simie Tsega
Asaye Alamneh Gebeyehu
Getaneh Atikilt Yemata
Rahel Mulatie Anteneh
Almaw Genet Yeshiwas
Getasew Yirdaw
Chalachew Yenew
Anley Shiferaw Enawgaw
Amare Genetu Ejigu
Ahmed Fentaw Ahmed
Zeamanuel Anteneh Yigzaw
Berhanu Abebaw Mekonnen
Meron Asmamaw Alemayehu
Abathun Temesgen
Abebaw Molla
Habitamu Mekonen
Assefa Andargie Kassa
Gashaw Melkie Bayeh
Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
BMC Infectious Diseases
Third line antiretroviral therapy
Viral load suppression
Africa
HIV
Systematic review and meta-analysis
title Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
title_full Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
title_fullStr Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
title_full_unstemmed Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
title_short Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
title_sort viral load suppression rate of third line antiretroviral therapy and its association with gender among hiv patients after second line treatment failure in africa a systematic review and meta analysis
topic Third line antiretroviral therapy
Viral load suppression
Africa
HIV
Systematic review and meta-analysis
url https://doi.org/10.1186/s12879-025-10576-4
work_keys_str_mv AT tilahundegutsega viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT sintayehusimietsega viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT asayealamnehgebeyehu viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT getanehatikiltyemata viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT rahelmulatieanteneh viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT almawgenetyeshiwas viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT getasewyirdaw viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT chalachewyenew viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT anleyshiferawenawgaw viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT amaregenetuejigu viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT ahmedfentawahmed viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT zeamanuelantenehyigzaw viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT berhanuabebawmekonnen viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT meronasmamawalemayehu viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT abathuntemesgen viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT abebawmolla viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT habitamumekonen viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT assefaandargiekassa viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis
AT gashawmelkiebayeh viralloadsuppressionrateofthirdlineantiretroviraltherapyanditsassociationwithgenderamonghivpatientsaftersecondlinetreatmentfailureinafricaasystematicreviewandmetaanalysis